1. From the Immunological Diseases, Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, Washington 98121; Department of Pathobiology and the Division of Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington 98195